Description

Global Health Limited confirms lock-in compliance for 20,000 equity shares allotted under Part B of GHL Employees Long Term Share Based Incentive Plan 2024, with lock-in periods ranging from 1 to 5 years.

Summary

Global Health Limited (Medanta) has submitted an undertaking to BSE confirming compliance with lock-in requirements under SEBI (Share Based Employee Benefit and Sweat Equity) Regulation, 2021 for listing and trading approval of 20,000 equity shares. These shares were allotted under Part B of the GHL Employees Long Term Share Based Incentive Plan 2024. The lock-in period commences from the date shares are transferred from the GHL Employees Welfare Trust to employees’ demat accounts.

Key Points

  • 20,000 equity shares allotted under Part B of GHL Employees Long Term Share Based Incentive Plan 2024
  • Lock-in requirements comply with SEBI (Share Based Employee Benefit and Sweat Equity) Regulation, 2021
  • Lock-in period commences from date of transfer from GHL Employees Welfare Trust to employee demat accounts
  • Minimum lock-in period: 1 year
  • Maximum lock-in period: 5 years
  • Lock-in to be implemented in phased manner based on different employee categories
  • Compliance ensured at the time of transfer to employee accounts

Regulatory Changes

No new regulatory changes introduced. This circular confirms compliance with existing SEBI (Share Based Employee Benefit and Sweat Equity) Regulation, 2021, specifically Regulation 22 regarding lock-in requirements.

Compliance Requirements

  • Global Health Limited must ensure lock-in requirements are enforced at the time of share transfer from trust to employee demat accounts
  • Lock-in period as per Regulation 22 and Para 15 of Part B of GHL Plan 2024 must be maintained
  • Phased lock-in implementation (1 to 5 years) must be applied based on employee category
  • Shares cannot be traded during the applicable lock-in period

Important Dates

  • September 01, 2025: Date of undertaking submission to BSE
  • Lock-in commencement: From the date shares are transferred from GHL Employees Welfare Trust to respective employee demat accounts (specific dates will vary by employee)
  • Lock-in duration: 1 year (minimum) to 5 years (maximum) from transfer date

Impact Assessment

Market Impact: Minimal. This is a routine listing approval for employee stock options involving only 20,000 shares, which represents a negligible portion of Global Health Limited’s equity base.

Operational Impact: Standard ESOP implementation with regulatory-compliant lock-in periods. The phased lock-in structure (1-5 years) provides flexibility while ensuring employee retention objectives.

Investor Impact: No direct impact on existing shareholders. The shares are subject to lock-in and cannot be immediately traded, preventing any dilution pressure on the stock price in the near term.

Impact Justification

Routine listing approval for employee stock plan with standard lock-in compliance. Limited market impact as it involves only 20,000 shares under ESOP scheme with regulatory lock-in requirements.